237 related articles for article (PubMed ID: 33184912)
1. Effect of Japanese herbal Kampo medicines on live birth rate in women with recurrent pregnancy loss.
Shigemi D; Hashimoto Y; Michihata N; Yasunaga H
Int J Gynaecol Obstet; 2021 Jun; 153(3):489-495. PubMed ID: 33184912
[TBL] [Abstract][Full Text] [Related]
2. Safety of Japanese herbal Kampo medicines for the treatment of depression during pregnancy.
Michihata N; Shigemi D; Yamana H; Matsui H; Jo T; Yasunaga H
Int J Gynaecol Obstet; 2022 Dec; 159(3):865-869. PubMed ID: 35490369
[TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of Japanese herbal Kampo medicines for treatment of hyperemesis gravidarum.
Michihata N; Shigemi D; Sasabuchi Y; Matsui H; Jo T; Yasunaga H
Int J Gynaecol Obstet; 2019 May; 145(2):182-186. PubMed ID: 30734286
[TBL] [Abstract][Full Text] [Related]
4. Impact of maternal depression and anxiety-related disorders on live birth rate in women with recurrent pregnancy loss.
Shigemi D; Hashimoto Y; Michihata N; Yasunaga H
Hum Fertil (Camb); 2022 Dec; 25(5):967-974. PubMed ID: 34282962
[TBL] [Abstract][Full Text] [Related]
5. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
[TBL] [Abstract][Full Text] [Related]
6. Current status of Kampo (Japanese herbal) medicines in Japanese clinical practice guidelines.
Motoo Y; Arai I; Hyodo I; Tsutani K
Complement Ther Med; 2009 Jun; 17(3):147-54. PubMed ID: 19398068
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Treatment Choices for Couples with Recurrent Pregnancy Loss Due to Structural Chromosomal Anomalies.
Maithripala S; Durland U; Havelock J; Kashyap S; Hitkari J; Tan J; Iews M; Lisonkova S; Bedaiwy MA
J Obstet Gynaecol Can; 2018 Jun; 40(6):655-662. PubMed ID: 29276169
[TBL] [Abstract][Full Text] [Related]
8. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
9. Prescription of Kampo Formulations for Pre-natal and Post-partum Women in Japan: Data From an Administrative Health Database.
Suzuki S; Obara T; Ishikawa T; Noda A; Matsuzaki F; Arita R; Ohsawa M; Mano N; Kikuchi A; Takayama S; Ishii T
Front Nutr; 2021; 8():762895. PubMed ID: 34869533
[No Abstract] [Full Text] [Related]
10. Incidence and clinical features of liver injury related to Kampo (Japanese herbal) medicine in 2,496 cases between 1979 and 1999: problems of the lymphocyte transformation test as a diagnostic method.
Mantani N; Kogure T; Sakai S; Goto H; Shibahara N; Kita T; Shimada Y; Terasawa K
Phytomedicine; 2002 May; 9(4):280-7. PubMed ID: 12120808
[TBL] [Abstract][Full Text] [Related]
11. Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicines.
Takeda T; Yamaguchi T; Yaegashi N
Int J Clin Oncol; 2012 Apr; 17(2):143-9. PubMed ID: 21706124
[TBL] [Abstract][Full Text] [Related]
12. Toxicological considerations of Kampo medicines in clinical use.
Ikegami F; Fujii Y; Satoh T
Toxicology; 2004 May; 198(1-3):221-8. PubMed ID: 15138045
[TBL] [Abstract][Full Text] [Related]
13. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
[TBL] [Abstract][Full Text] [Related]
14. Preimplantation Genetic Diagnosis and Natural Conception: A Comparison of Live Birth Rates in Patients with Recurrent Pregnancy Loss Associated with Translocation.
Ikuma S; Sato T; Sugiura-Ogasawara M; Nagayoshi M; Tanaka A; Takeda S
PLoS One; 2015; 10(6):e0129958. PubMed ID: 26083495
[TBL] [Abstract][Full Text] [Related]
15. A proposed prognostic prediction tool for a live birth among women with recurrent pregnancy loss.
Bashiri A; Giliutin M; Ziedenberg H; Plakht Y; Baumfeld Y
J Matern Fetal Neonatal Med; 2022 Oct; 35(19):3736-3742. PubMed ID: 33135531
[TBL] [Abstract][Full Text] [Related]
16. Contribution of traditional Japanese Kampo medicines, kakkonto with shosaikotokakikyosekko, in treating patients with mild-to-moderate coronavirus disease 2019: Further analysis of a multicenter, randomized controlled trial.
Takayama S; Namiki T; Arita R; Ono R; Kikuchi A; Ohsawa M; Saito N; Suzuki S; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Takagi A; Yamaguchi T; Ishii T; Hisanaga A; Mitani K; Ito T
J Infect Chemother; 2023 Nov; 29(11):1054-1060. PubMed ID: 37507087
[TBL] [Abstract][Full Text] [Related]
17. Index pregnancy versus post-index pregnancy in patients with recurrent pregnancy loss.
Greenberg T; Tzivian L; Harlev A; Serjienko R; Mazor M; Bashiri A
J Matern Fetal Neonatal Med; 2015 Jan; 28(1):63-7. PubMed ID: 24592815
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of the presence of an embryonic heartbeat for live birth: comparison of women with and without recurrent pregnancy loss.
Hyer JS; Fong S; Kutteh WH
Fertil Steril; 2004 Nov; 82(5):1369-73. PubMed ID: 15533362
[TBL] [Abstract][Full Text] [Related]
19. Kampo medicines as alternatives for treatment of migraine: six case studies.
Ishida K; Sato H
Complement Ther Clin Pract; 2006 Nov; 12(4):276-80. PubMed ID: 17030300
[TBL] [Abstract][Full Text] [Related]
20. Primary vs. secondary recurrent pregnancy loss--epidemiological characteristics, etiology, and next pregnancy outcome.
Shapira E; Ratzon R; Shoham-Vardi I; Serjienko R; Mazor M; Bashiri A
J Perinat Med; 2012 Feb; 40(4):389-96. PubMed ID: 22752770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
